Tenaya Therapeutics

Tenaya Therapeutics is a biopharmaceutical company dedicated to discovering and developing therapies for heart failure. Founded by world-class scientists from the Cardiovascular Division of the Gladstone Institutes and UT Southwestern, and supported by The Column Group, Tenaya is building a research-driven organization that leverages cutting-edge science in cardiac regeneration, induced pluripotent stem cells, and CRISPR technology to target fundamental cellular pathologies present in diseased myocardium.